跳至主要内容
临床试验/NL-OMON52401
NL-OMON52401招募中不适用

Evaluation of genetic, enzymatic, biochemical and clinical characteristics of OCTN2/CPT2/CACT/BKT deficiency to determine if new born screening is useful and feasible - OCTN2/CPT2/CACT/BKT Deficiency Implementation in Newborn screening: ODI

niversitair Medisch Centrum Utrecht0 个研究点目标入组 380 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
380

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
0 至 99(—)

入选标准

  • OCTN2 deficiency, confirmed by reduced carnitine transporter activity in
  • cultured fibroblasts and/or mutations in the SLC22A5 gene.
  • Subject referred to academic centre for OCTN2 deficiency because of low
  • carnitine level in NBS.
  • Mother analysed in academic centre for OCTN2 deficiency due to low carnitine
  • level in infant*s NBS.
  • CPT2 deficiency, confirmed by reduced Carnitine palmitoyltransferase II
  • activity in lymphocytes or cultured fibroblasts and/or biallelic mutations in
  • the CPT2 gene.
  • CACT deficiency, confirmed by carnitine acylcarnitine translocase activity in
  • cultured fibroblasts and/or biallelic mutations in the SLC25A20 gene.
  • BKT deficiency, confirmed by reduced 2-methylacetoacetyl-CoA thiolase
  • activity in cultured fibroblasts and/or biallelic mutations in the ACAT1 gene.

排除标准

  • No exclusion criteria. All subjects that meet inclusion criteria are elligible
  • for inclusion

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验

Evaluation of genetic, enzymatic, biochemical and... | 临床试验